1. The turnover of 1251-labelled lactoferrin was measured in ten adults. Simultaneous organ radioactivity counting was performed.
Introduction
Lactoferrin, an iron-binding protein of molecular weight 77 OOO (Querinjean, Masson & Heremans, 1971) , is found in many human secretions Masson, Heremans & Dive, 1966; Biserte, Havez & Cuvelier, 1968; Masson, Heremans, Schonne & Crabbe, 1968; Bennett, Quartey & Holt, 1973; Franklin, Kenyon & Tomasi, 1973; Broekhuyse, 1974; Figarella & Sarles, 1975) and in neutrophils (Masson, Heremans & Schonne, 1969; Bennett & Kokocinski, 1978; de Vet & ten Hoopen, 1978) . The concentration of lactoferrin in human plasma is-about 0.2-1.5 pg/ml (Rumke, Visser, Kwa & Hart, 1971) , with women having somewhat lower values than men (Bennett & Mohla, 1976) . We have measured neutrophil lactoferrin concentrations at about 15 pg/106 cells; as with plasma, lower values are seen in women (Bennett & Kokocinski, 1978) . Different investigators have reported other concentrations (Masson et al., 1969; Rumke et al., 1971; Leffell & Spitznagel, 1975; Olsson, Verge & Elgefors, 1977b; de Vet & ten Hoopen, 1978) . Neutrophil lactoferrin is associated with the secondary (specjfic) granules (Baggiolini, De Duve, Masson & Heremans, 1970; Spitznagel, Dalldorf, Leffell, Folds, Welsh, Cooney & Martin, 1974) , and is released isochronously with other lysosomal proteins during phagocytosis (Van Snick, Masson & Heremans, 1974; Leffell & Spitmagel, 1975; Bennett & Skosey, 1977) . On the basis of an absence of plasma lactoferrin in agranulocytosis (Bennett & Kokocinski, 1978) , low plasma concentrations in neutropenic states (Olofson et al., 1977b ) and a correlation of plasma values with the total neutrophil pool (Hansen, Malmquist & Thorell, 1975) , it is postulated that plasma lactoferrin is derived from neutrophils. Previous work on lysozyme (Osserman, 1974) , which has a wellestablished association with circulating leucocytes (Hansen & Anderson, 1973; Briggs, Pasquale & Finch, 1966) has demonstrated the feasibility of using data from turnover studies, cellular concentrations and plasma concentrations, in assessing neutrophil turnover (Hansen, 1974) . Unlike lysozyme, lactoferrin is virtually specific for neutrophils, only trace amounts being found on the surface of monocytes (Bennett & Kokocinski, 1978) . As neutrophil-derived lactoferrin is in an irondepleted state (apolactoferrin) there has been speculation that its release may be associated with the hypoferraemia of inflammation (Bennett, Holt & Lewis, 1974; Van Snick et al., 1974; Hansen, Karle, Andersen, Malmquist & Hoff, 1976) . Recent work has shown a significant relationship between neutrophil lactoferrin concentrations and plasma iron concentrations (de Vet & ten Hoopen, 1978) . With these considerations in mind, the present study has measured lactoferrin turnover in man, relating it to 'derived neutrophil turnover' and ferrokinetics.
Methods

Subjects
Turnover studies with 129-labelled lactoferrin were performed on nine healthy volunteer subjects and one patient with chronic renal failure. Three subjects had additional studies with [59Fe]lactoferrin and one other subject was restudied with lZ5I-labelled apolactoferrin. Subjects receiving lZ5I were given 500 mg of sodium iodide orally for 3 days before the start of the study; this was continued for a further 3 weeks. The study was approved by the Radiation Safety Committee and the Clinical Research Committee at the University of Chicago. Informed written consent was obtained from each volunteer before the onset of the study. The details of the ten subjects are given in Table 1 .
Preparations
Lactoferrin was isolated from human breast milk as previously outlined (Bennett & Mohla, 1976) . The purity was assessed by cationic polyacrylamide gel disc electophoresis, with a 7.5% acrylamide gel with a running pH of 4.5 (Bennett & Kokocinski, 1978) and further verified by immunoelectrophoresis (Bennett & Mohla, 1976) .
Plasma and cellular lactoferrin were measured by a solid-phase radioimmunoassay (Bennett & Mohla, 1976) .
The preparation of plasma for assay and the extraction of lactoferrin from purified neutrophil preparations has been described previously (Bennett & Kokocinski, 1978) .
Iodination of lactoferrin with 1251 (New England Nuclear Corp.) was accomplished with a modification of the chloramine-T method (Greenwood, 
Experimental procedure
Labelled lactoferrin was diluted with sterile sodium chloride solution (0.9%; saline) to make an approximate volume of 3 ml(20 j C i of 1251-labelled lactoferrin and 3 &i of [59Fellactoferrin). Volumes (100 pl) of both 1251-labelled and 5gFe-labelled lactofemn were diluted 1 : 100 and 1 ml of this was kept as a standard. The labelled lactoferrin was injected into an antecubital vein over the course of about 10 s; the amount given was determined by weighing the syringe before and after injection. Blood samples were drawn into heparinized tubes over 3 day periods, as shown in the Figures. Urine collections were made over 24 h periods. For the lZ5I studies plasma and urine were treated with 10%
trichloroacetic acid and the radioactivities of the plasma and urinary precipitates and supernatants were measured in a gamma counter (Beckman Biogamma). For the 59Fe studies hepariniied blood samples were taken over the course of 30 days and radioactivity was measured in separated erythrocytes and plasma (for calculation of erythrocyte incorporation of 59Fe); 24 h urine collections were made as for the 1251-labelled lactoferrin. In those patients given SgFe sacral radioactivity counting was also done. All plasma, urine and organ counts were adjusted for background and decay.
Calculations
Turnover results were calculated from the plasma disappearance curve of trichloroacetic acidprecipitable radioactivity counts, the 'peel-off' technique described by Nosslin & Donata (1966) being used. Individual values were inserted in a programme for exponential regression (Hewlett Packard 29C calculator) and the correlation coefficient (r) was determined, as a check on the experimental data. The initial plasma radioactivity was calculated by exponential regression of the counts taken over the first 15 min. Plasma disappearance curves were constructed as semilogarithmic plots of the plasma radioactivity (expressed as a percentage of the initial radioactivity) against time. The individual plasma disappearance curves were divided into two exponential functions, expressed by an intercept A, or A, and a slope B , or B,. The plasma radioactivity ( x ) at time t was expressed as the sum of these two exponential terms:
The calculation of fractional catabolic rate (FCR) was based on the formula derived by Matthews (1957). Packed cell volume 'Intravascular senescence of neutrophils/day' is a 'calculated value' of neutrophil turnover, and is only about 1% of the value that has been obtained by actual cell kinetic data. It is surmized that it represents intravascular senescence of neutrophils (see the Results and Discussion sections).
Combined results are expressed as the arithmetical mean f SD. Both linear and exponential regression equations were generated by standard programmes on a Hewlett Packard 29C calculator; the correlation coefficient and its standard error were calculated by conventional formulae (Snedecor & Cochran, 1967) : no significance, P < 0.05.
Results
Turnover data
Nine healthy subjects ranging in age from 21 to 62 years, comprising five males and four females, underwent 1251-labelled lactoferrin metabolic studies. Gel chromatography and charcoalhextran separation confirmed that 0.1% of the lactofemn was in an aggregated form. The plasma decay curve was resolved into two exponential functions. The mean half-life of the first exponent was 1-26 h (SD f 0.49) and 16.63 h (SD f 2.78) for the second exponent. Introducing the experimental points into an exponential curve fitting programme gave an r value of 0.86 for all data points of the first exponent and an r value of 0.91 for all data points of the second exponent. The average fractional catabolic rate (FCR) was 5.71 (SD f 0+96)/day; there was no significant variation between males and females: males 5.6 (SD f 0.63) and females 5-54 (SD & 0.72).
Assuming the plasma lactoferrin to be in a steady state, the mean synthetic rate was 16.8 mg/day (SD f 8.6). For males the synthetic rate was 18-8 mg/day (SD 9.2) and for females 14.4 mg/day (SD k 8.4); with the small numbers studied this difference is not statistically significant. These results are summarized in Table 2 .
Radioactivity of 24 h urine specimens indicated that there was no glomerular leakage of 1251-labelled lactoferrin but 98% of non-trichloroacetic acid-precipitable radioactivity counts were eliminated within the first 24 h; this finding made it impossible to combine plasma and urine radioactivity in computing metabolic indices. In marked contradistinction there was no urinary elimination of 59Fe in those subjects given [59Fe]lactoferrin.
One subject (F) was studied with both lactofemn (95% iron-saturated) and apolactoferrin, with an interval of 2 months in between studies.
The apolactoferrin on gel chromatography and charcoal/dextran separation contained 46% of aggregated molecules, which probably accounted for a very rapid initial clearance with the first exponent (2'4 = 0.6 h). Despite this, the overall clearance of apolactoferrin was slower than lactoferrin (relative T, of the two exponents, 38.0 rnin and 18.1 h). This is reflected in an apolactoferrin FCR of 1-22/day vs 5.26/day for lactoferrin (see Fig. 1 ).
Organ distribution of I2'I and 59Fe radioactivity
Surface radioactivity counting was performed routinely over the liver, spleen, bladder and sacrum. In the case of the lZ5I-labelled lactoferrin there was a prompt accumulation of radioactivity over the liver, maximal at 12-30 min, followed by a rapid decline in radioactivity, reaching zero by 7 h post-injection. Spleen radioactivity counts were iso- chronous with liver counts, but about one-third the radioactivity. Simultaneous bladder counts revealed a progressive accumulation of radioactivity over the first 6 h, with a tendency to reach a plateau at 6-7 h; voiding at 6) h resulted in a return to almost zero counts, indicating that the radioactivity was indeed in the urine. In the case of PFellactoferrin a Merent pattern of organ radioactivity counting was observed. The initial accumulation in the liver was similar to 1251 (maximum at 10-15 min) but thereafter there was a very slow reduction in liver radioactivity (Fig. 2) . No '9Fe counts were detected over the bladder during Time (h)
FIG. 2. Fractional radioactivity of [59Fellactoferrin and
121-labeUed lactoferrin, expressed as a multiple of counts at zero time, as measured by surface counting over the liver with 59Fe (n) or with 12'1 ( 0 ) and over the bladder with 12JI (A). That radioactivity counts were accumulating in the urine is seen in the rapid decline in bladder counts (broken line) after micturition at 4 h. Whereas 12sI is rapidly cleared from the liver and excreted in the urine, 59Fe is retained by the liver and none is detectable in the urine (not shown).
the first 12 h, nor was any 1'9Fe excreted in the urine. Sacral radioactivity counts (representing bone marrow), began to accumulate after the first 24 h, reaching a peak at days 12, 7 and 4 respectively for the three subjects. The uptake of 59Fe into the bone marrow was accompanied by its utilization in erythropoiesis and reflected by a progressive accumulation of 59Fe into circulating erythrocytes ( Fig. 3 and Table 3 ). There was no accumulation of 59Fe in neutrophils. Time ( 
Discussion
This study shows that lactoferrin is rapidly cleared from the circulation, being avidly sequestered by the liver and spleen. The rapid appearance of free lZ5I in the urine suggests that the sequestered lactoferrin is promptly catabolized (unless the 1251 is selectively removed). The studies utilizing IJ9Fel-lactoferrin showed a similar rapid uptake by the liver and spleen; however, the iron is not excreted in the urine, but rather retained and slowly transferred to the bone marrow, where it is subsequently incorporated into developing erythrocytes. These results are based on lactoferrin derived from human breast milk and not from neutrophils. It is possible that minor differences in chemical composition of neutrophil lactoferrin and milk lactoferrin would lead to significant changes in clearance rates. The feasibility of comparative studies has been hampered by the inability to isolate neutrophil lactoferrin in a disaggregated state; however, double immunodiffusion analysis has not revealed any obvious disparity between lactoferrin derived from breast milk, colostrum, apolactoferrin and neutrophil lactoferrin (Bennett & Kokocinski, 1978) . Recent work has shown that neutrophil-derived lactoferrin is in an iron-depleted state (Van Snick et al., 1974; Bennett & Kokocinski, 1978) , and has an equilibrium constant for Fe3+ 300 times greater than that of transferrin, in a pH range 6.4-6.7 (Aisen & Leibman, 1972) . It has been hypothesized, from animal experiments, that apolactoferrin will bind free iron, and under the slightly acidic condition of inflammatory exudates there will be an exchange of iron from transferrin to apolactoferrin; the resulting Fe-lactoferrin will be rapidly sequestered by the reticuloendothelial system. As normal erythropoiesis preferentially utilizes transferrin-bound iron, derived mainly from effete erythrocytes, reticuloendothelial-sequestered iron, from lactoferrin, will be less readily available for incorporation into developing erythrocytes. The work of Masson's group has further clarified this sequence by showing that macrophages have surface receptors for lactoferrin (Van Snick & Masson, 1976 ) and membrane-bound lactofemn is ingested with subsequent transfer of its iron to ferritin (Van Snick, Markowetz & Masson, 1977) . A hypothesis has been formulated implying that the release of apolactoferrin, at sites of inflammation, may be a contributing factor to the concomitant hyposideraemia (Van Snick et al., 1974) . Our results add further support to this hypothesis in man: lactoferrin is avidly sequestered by the liver and spleen and its iron is only slowly made available for erythropoiesis (Fig. 2) This hypothesis is lent some support by two recent observations. In chronic myeloid leukaemia elevated plasma lactoferrin concentrations have been reported (Malmquist, 1972 ; Olofson, Olsson & Verge, 1977a) , whereas in the neutrophilia of acute idammation plasma lactoferrin is not notably elevated (Hansen et al., 1976) . In chronic myeloid leukaemia there is not a conspicuous efflux of neutrophils from the circulation and a high rate of intravascular senescence might be expected. In acute inAammation neutrophils will be sequestered at the focus of inflammation and their subsequent breakdown will be mainly extravascular with minimal intravascular senescence. The work of Broxmeyer and colleagues (Broxmeyer, Smithyman, Eger, Myers & Desousa, 1978) has demonstrated that lactoferrin is the granulocytederived inhibitor of colony-stimulating activity production. Whether this work in uftro is an indication that neutrophil senescence and subsequent lactoferrin release constitute a negative feedback mechanism of physiological importance will be an exciting area for future research.
